Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-026-04323-8
Affiliations:
33
Authors:
39
Go to article
Institutions Authors Share
OncoC4, Inc., United States of America (USA)
4.000000
 0.10
BioNTech, Germany
3.000000
 0.08
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China
2.000000
 0.05
Florida Cancer Specialists and Research Institute (FCS), United States of America (USA)
2.000000
 0.05
Yonsei Cancer Hospital, South Korea
1.000000
 0.03
Ocala Oncology Center, United States of America (USA)
1.000000
 0.03
Zhejiang Cancer Hospital (ZJCH), China
1.000000
 0.03
Dongguan People's Hospital, China
1.000000
 0.03
Chengdu Seventh People's Hospital (Chengdu Tumor Hospital), China
1.000000
 0.03
Renmin Hospital of Wuhan University/Hubei General Hospital, China
1.000000
 0.03
Hubei Cancer Hospital (HBCH), China
1.000000
 0.03
University of Cincinnati (UC), United States of America (USA)
1.000000
 0.03
Norton Cancer Institute, United States of America (USA)
1.000000
 0.03
Hainan General Hospital, China
1.000000
 0.03
Hunan Cancer Hospital, China
1.000000
 0.03
Xiangya Hospital, CSU, China
1.000000
 0.03
Springfield Clinic, United States of America (USA)
1.000000
 0.03
Messino Cancer Centers, United States of America (USA)
1.000000
 0.03
University of Tennessee Medical Center (UTMC), United States of America (USA)
1.000000
 0.03
Chungnam National University Hospital (CNU Hospital), CNU, South Korea
1.000000
 0.03
Dongsan Medical Center, KMU, South Korea
1.000000
 0.03
National Cancer Center (NCC), South Korea
1.000000
 0.03
Hospital and Cancer Center, CQU, China
1.000000
 0.03
First Affiliated Hospital, GDPU, China
1.000000
 0.03
Jinan Central Hospital, China
1.000000
 0.03
Harbin Medical University Cancer Hospital, China
1.000000
 0.03
Mater Hospital Brisbane, Australia
1.000000
 0.03
BioNTech US, United States of America (USA)
1.000000
 0.03
R and G - U.S., United States of America (USA)
1.000000
 0.03
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
1.000000
 0.03
UC Davis Comprehensive Cancer Center, United States of America (USA)
1.000000
 0.03
AdventHealth, United States of America (USA)
1.000000
 0.03
Interested in Oncology and Carcinogenesis?